News

Filter

Current filters:

Men's HealthLicensing

1 to 9 of 17 results

Trimel and Endo agree on Natesto manufacturing and marketing collaboration

Trimel and Endo agree on Natesto manufacturing and marketing collaboration

24-11-2014

Trimel Biopharma, a subsidiary of Canada's Trimel Pharmaceuticals Corp, has signed an agreement with…

CanadaEndoLicensingMarkets & MarketingMen's HealthPharmaceuticalTrimel PharmaceuticalsUSA

Forendo licenses fispemifene to Apricus in USA

20-10-2014

Finland-based Forendo Pharma, a Swedish firm Karolinska Development portfolio company, has entered into…

Apricus BiosciencesfispemifeneForendo PharmaGenito-urinaryKarolinska DevelopmentLicensingMen's HealthPharmaceuticalUSA

Plethora signs licensing agreement with Recordati for premature ejaculation drug

Plethora signs licensing agreement with Recordati for premature ejaculation drug

16-09-2014

Urological specialist Plethora Solutions has signed a licensing agreement with international pharma group…

EuropeLicensingMen's HealthPharmaceuticalPlethoraPSD502Recordati

Sanofi and Lilly announce licensing agreement for Cialis OTC

Sanofi and Lilly announce licensing agreement for Cialis OTC

28-05-2014

French drug major Sanofi and US drug major Eli Lilly have agreed to pursue regulatory approval of non-prescription…

CialisEli LillyEli Lilly and CompanyEuropean Medicines AgencyFranceLicensingMen's HealthPDE5 inhibitorsPharmaceuticalSanofiTreatment of men with erectile dysfunctionVincent Warnery

Ampio’s Vyrix unit out-licenses certain rights for Zertane to Paladin

10-04-2014

USA-based biotech firm Ampio Pharmaceuticals says its wholly-owned subsidiary Vyrix Pharmaceuticals…

Ampio PharmaceuticalsBiotechnologyEndo Health SolutionsLicensingMen's HealthPaladin LabsVyrix PharmaceuticalsZertane

Recordati gains certain rights to Apricus’ Vitaros

10-02-2014

Italian drugmaker Recordati has signed an exclusive license agreement with the USA’s Apricus Biosciences…

Apricus BioscienceEastern EuropeLicensingMen's HealthPharmaceuticalRecordatiRest of the WorldTurkeyVitaros

Apricus expands Vitaros deal with Novartis unit

Apricus expands Vitaros deal with Novartis unit

16-12-2013

USA-based Apricus Biosciences has expanded its exclusive license agreement with Hexal AG, an affiliate…

Apricus BioscienceEuropeLicensingMen's HealthNovartisPharmaceuticalSandozVitaros

Sanofi to commercialize Vivus ED drug in Africa, Middle East, Turkey and CIS/Russia

Sanofi to commercialize Vivus ED drug in Africa, Middle East, Turkey and CIS/Russia

12-12-2013

US drugmaker Vivus has entered into a license and commercialization agreement with French pharma major…

avanafilEastern EuropeLicensingMarkets & MarketingMen's HealthPharmaceuticalRest of the WorldSanofiVivus

1 to 9 of 17 results

Back to top